291 related articles for article (PubMed ID: 19058304)
1. Dynamic localization of hepatocellular transporters in health and disease.
Roma MG; Crocenzi FA; Mottino AD
World J Gastroenterol; 2008 Nov; 14(44):6786-801. PubMed ID: 19058304
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Localization of Hepatocellular Transporters: Role in Biliary Excretion and Impairment in Cholestasis.
Roma MG; Barosso IR; Miszczuk GS; Crocenzi FA; Pozzi EJS
Curr Med Chem; 2019; 26(7):1113-1154. PubMed ID: 29210641
[TBL] [Abstract][Full Text] [Related]
3. Localization status of hepatocellular transporters in cholestasis.
Crocenzi FA; Zucchetti AE; Boaglio AC; Barosso IR; Sanchez Pozzi EJ; Mottino AD; Roma MG
Front Biosci (Landmark Ed); 2012 Jan; 17(4):1201-18. PubMed ID: 22201798
[TBL] [Abstract][Full Text] [Related]
4. Regulation of synthesis and trafficking of canalicular transporters and its alteration in acquired hepatocellular cholestasis. Experimental therapeutic strategies for its prevention.
Crocenzi FA; Mottino AD; Roma MG
Curr Med Chem; 2004 Feb; 11(4):501-24. PubMed ID: 14965230
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects.
Roma MG; Crocenzi FA; Sánchez Pozzi EA
Clin Sci (Lond); 2008 May; 114(9):567-88. PubMed ID: 18377365
[TBL] [Abstract][Full Text] [Related]
6. Oxidative Stress and Localization Status of Hepatocellular Transporters: Impact on Bile Secretion and Role of Signaling Pathways.
Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ; Roma MG
Antioxid Redox Signal; 2021 Oct; 35(10):808-831. PubMed ID: 34293961
[No Abstract] [Full Text] [Related]
7. Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis.
Razori MV; Maidagan PM; Ciriaci N; Andermatten RB; Barosso IR; Martín PL; Basiglio CL; Sánchez Pozzi EJ; Ruiz ML; Roma MG
Biochem Pharmacol; 2019 Oct; 168():48-56. PubMed ID: 31202734
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanisms of bile formation and cholestatic diseases].
Poupon R
Bull Acad Natl Med; 2003; 187(7):1261-74; discussion 1274-6. PubMed ID: 15146603
[TBL] [Abstract][Full Text] [Related]
9. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
Stieger B; Mahdi ZM
J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
[TBL] [Abstract][Full Text] [Related]
10. Regulation of plasma membrane localization of the Na+-taurocholate cotransporting polypeptide (Ntcp) by hyperosmolarity and tauroursodeoxycholate.
Sommerfeld A; Mayer PG; Cantore M; Häussinger D
J Biol Chem; 2015 Oct; 290(40):24237-54. PubMed ID: 26306036
[TBL] [Abstract][Full Text] [Related]
11. Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.
Ali I; Khalid S; Stieger B; Brouwer KLR
Mol Pharm; 2019 Mar; 16(3):1406-1411. PubMed ID: 30608704
[TBL] [Abstract][Full Text] [Related]
12. Transporters on demand: intrahepatic pools of canalicular ATP binding cassette transporters in rat liver.
Kipp H; Pichetshote N; Arias IM
J Biol Chem; 2001 Mar; 276(10):7218-24. PubMed ID: 11113123
[TBL] [Abstract][Full Text] [Related]
13. Cholestasis: the ABCs of cellular mechanisms for impaired bile secretion--transporters and genes.
Shaffer EA
Can J Gastroenterol; 2002 Jun; 16(6):380-9. PubMed ID: 12096302
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of cholestatic liver diseases.
Paumgartner G
J Dig Dis; 2010 Jun; 11(3):119-25. PubMed ID: 20579215
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms.
Wang T; Zhou ZX; Sun LX; Li X; Xu ZM; Chen M; Zhao GL; Jiang ZZ; Zhang LY
Acta Pharmacol Sin; 2014 Dec; 35(12):1527-36. PubMed ID: 25418378
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of canalicular transporter endocytosis in the cholestatic rat liver.
Miszczuk GS; Barosso IR; Larocca MC; Marrone J; Marinelli RA; Boaglio AC; Sánchez Pozzi EJ; Roma MG; Crocenzi FA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1072-1085. PubMed ID: 29355600
[TBL] [Abstract][Full Text] [Related]
18. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
[TBL] [Abstract][Full Text] [Related]
19. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
Beuers U
Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
